BSI CTMS 25.2: Enhanced Monitoring, Unblinding, and Operational Efficiency
Baden, Switzerland, December 15, 2025 - BSI Life Sciences, an eClinical solutions provider, announces the release of BSI CTMS 25.2, a new version that builds on the major platform enhancements delivered earlier this year in version 25.1.
BSI CTMS 25.2 delivers updates across monitoring, unblinding, and operational workflows. Monitoring capabilities have been expanded with support for several feasibility assessment types, more options for role restrictions for monitoring visits, multi-language confirmation, and follow-up letters. These improvements further help teams manage global studies.
To support this, the release also improves unblinding functionality,including clear marking of unblinded data and extensions of unblinding features to other modules. Address management now features improved Google integration and mirroring of addresses.
In addition, BSI CTMS 25.2 introduces new and enhanced importers, including a person assignment importer and an enhanced site importer, simplifying data setup and maintenance.
“BSI CTMS 25.2 reflects our ongoing commitment to listening to our customers and delivering enhancements that make running clinical trials more efficient,” said Jakub Surina, Global Head of Business Development at BSI Life Sciences. “These updates build on the strong foundation of our earlier 25.1 release and help teams work more effectively across increasingly complex trials.”
This release underscores BSI Life Sciences’ commitment to continuous innovation across its eClinical portfolio. With a strong development roadmap and a customer-driven approach, BSI Life Sciences is actively delivering new capabilities that help organizations run trials more efficiently today, while preparing for the operational challenges of tomorrow. Additional enhancements are already in development and will continue to expand the value of the BSI eClinical platform.
Media Contact Details
BSI Business Systems Integration AG
Täfernweg 1, 5405 Baden, Switzerland
Anna Bjarakdottir
About BSI Life Sciences
BSI Life Sciences offers smart eClinical software for CTMS, eTMF and more. BSI makes life science software for people – and has done so for 27+ years. BSI’s software solutions are made in Switzerland, Germany, USA, and anywhere else clients need them to be. They are both innovative and user-friendly.
BSI focuses its resources on staying ahead of the trends and delivering functional, compliant, and affordable eClinical software. With this mission, BSI helps its customers continuously optimize and accelerate the clinical development process. And that’s what they love!
For more information, please visit: www.bsi-lifesciences.com
